Sains Malaysiana 53(5)(2024): 1185-1199
http://doi.org/10.17576/jsm-2024-5305-16
Lipoprotein Oxidation, Genetic Expression and
Polymorphism of Apo A and B Gene in Patients with Coronary Artery
Disease in a Pakistani Punjabi Population
(Pengoksidaan Lipoprotein, Ekspresi Genetik dan Polimorfisme Gen Apo A dan B pada Pesakit Penyakit Arteri Koronari dalam Kalangan Penduduk Pakistani Punjabi)
HIRA
SOHAIL1,2,*,
MADEEHA SHAHZAD2, SABA KHALIQ3 & FARHAT IJAZ1
1Combined Military Hospital Lahore
Medical College and Institute of Dentistry, Lahore, Pakistan
2The University of Lahore, Pakistan
3University of Health Sciences,
Lahore, Pakistan
Diserahkan: 27 September 2023/Diterima: 20 Mac 2024
Abstract
Oxidative
alterations of lipoproteins and numerous polymorphism locations in the apolipoprotein A1 (APOA1) and B (APOB) genes have been identified as risk factors for cardiovascular events. The aim
of the study was to investigate the gene expression and the role of APOA and B gene polymorphisms in coronary artery disease (CAD) and their
relationship with lipid profiles, oxidized High Density Lipoprotein (oxHDL), and oxidized Low Density Lipoprotein (oxLDL) in the Punjabi Pakistani population. A total of 200
subjects were included, of which 135 were diagnosed as having CAD and 65 were
not. The lipid profile, oxHDL, and oxLDL were measured through the calorimetric method and
ELISA, respectively. Quantitative variables represented by mean ± SD for
normally distributed data. Gene expression was done on cDNA through Real-time
PCR. Genotyping of APOA1 (rs670, rs5069) and APOB (rs693,
rs11279109) were performed by PCR-RFLP (Polymerase Chain Reaction-Restriction
Fragment Length Polymorphism), and gel electrophoresis was used for band
visualization. Our findings showed that the oxHDL, oxLDL, APOA, B gene expression and Del
genotype of APOB rs11279109 was significantly increased in CAD cases. In
addition, significant high levels of oxHDL, oxLDL, serum cholesterol, VLDL, TG, and cholesterol/HDL
ratio has been shown to be associated with CAD. APOB (rs11279109) has a
significant impact on dyslipidemia and exhibit a higher risk of CAD (OR=3.97)
while, APOB (rs693), APOA1 (rs670), (rs5069) possesses a lower
risk of CAD in the population. Hence, levels of oxHDL and oxLDL as well as ApoA1 and APOB genotyping could be useful in identifying individuals who are at risk of CAD.
Keywords: APOA1 gene; APOB gene; coronary artery disease; dyslipidemia; oxHDL; oxLDL
Abstrak
Perubahan oksidatif lipoprotein dan banyak lokasi polimorfisme dalam gen apolipoprotein A1 (APOA1) dan B (APOB) telah dikenal pasti sebagai faktor risiko gangguan kardiovaskular. Matlamat penyelidikan ini adalah untuk mengkaji pengekspresan gen dan peranan polimorfisme gen APOA dan B dalam penyakit arteri koronari (CAD) dan hubungannya dengan profil lipid, lipoprotein ketumpatan tinggi (oxHDL) teroksida dan lipoprotein ketumpatan rendah (oxLDL) teroksida dalam kalangan penduduk Punjabi Pakistan. Sebanyak 200 subjek telah dimasukkan dalam kajian ini dengan 135 daripadanya telah didiagnosis sebagai mempunyai CAD dan 65 tidak. Profil lipid, oxHDL dan oxLDL diukur masing-masing melalui kaedah kalorimetrik dan ELISA. Pemboleh ubah kuantitatif diwakili oleh min ± SD untuk data taburan normal. Pengekspresan gen dilakukan pada cDNA melalui PCR masa nyata. Genotaip APOA1 (rs670, rs5069) dan APOB (rs693, rs11279109) telah dilakukan oleh PCR-RFLP (Tindak Balas Berantai Polimerase - Polimorfisme Pemotongan Panjang Cebisan (PCR-RFLP)) dan elektroforesis gel digunakan untuk visualisasi jalur. Penemuan kami menunjukkan bahawa pengekspresan gen oxHDL, oxLDL, APOA, B dan genotip Del APOB rs11279109 meningkat dengan ketara dalam kes CAD. Di samping itu, paras tinggi oxHDL, oxLDL, kolesterol serum, VLDL, TG dan nisbah kolesterol/HDL yang tinggi telah terbukti dikaitkan dengan CAD. APOB (rs11279109) mempunyai kesan yang ketara terhadap dislipidemia dan menunjukkan risiko CAD yang lebih tinggi (OR=3.97) manakala, APOB (rs693), APOA1 (rs670),
(rs5069) mempunyai risiko CAD yang lebih rendah dalam populasi. Oleh itu, tahap oxHDL dan oxLDL serta genotaip ApoA1 dan APOB boleh berguna dalam mengenal pasti individu yang berisiko mendapat CAD.
Kata kunci: Dislipidemia; gen APOA1;
gen APOB; oxHDL; oxLDL; penyakit arteri koronari
RUJUKAN
Abd El-Aziz, T.A. & Mohamed, R.H.
2016. LDLR, ApoB and ApoE genes polymorphisms and classical risk factors in premature coronary artery
disease. Gene 590(2): 263-269.
https://doi.org/10.1016/j.gene.2016.05.032
Al-Bustan, S.A., Alnaqeeb, M.A., Annice, B.G., Ebrahim, G.A. & Refai, T.M. 2014. Genetic association of APOB
polymorphisms with variation in serum lipid profile among the Kuwait
population. Lipids in Health and Disease 13: 157. DOI:
10.1186/1476-511X-13-157
Al-Bustan,
S.A., Al-Serri, A.E., Annice,
B.G., Alnaqeeb, M.A. & Ebrahim,
G.A. 2013. Re-sequencing of the APOAI promoter region and the genetic
association of the-75G> A polymorphism with increased cholesterol and low
density lipoprotein levels among a sample of the Kuwaiti population. BMC
Medical Genetics 14: 90. doi:10.1186/1471-2350-14-90
Boekholdt, S.M., Peters, R.J., Fountoulaki, K., Kastelein, J.J.
& Sijbrands, E.J. 2003. Molecular variation at
the apolipoprotein B gene locus in relation to lipids
and cardiovascular disease: A systematic meta-analysis. Human Genetics 113: 417-425. DOI: 10.1007/s00439-003-0988-3
Bogari, N.M., Abdel-Latif, A.M., Hassan,
M.A., Ramadan, A. & Fawzy, A. 2015. No
association of apolipoprotein B gene polymorphism and
blood lipids in obese Egyptian subjects. Journal of Negative Results in
Biomedicine 14: 7. doi: 10.1186/s12952-
015-0026-8
Burgos
Alves, M.I., Avilés Plaza, F., Martínez-Tomás,
R., Sánchez-Campillo, M., Larqué,
E., Pérez-Llamas, F., Martínez Hernández, P. &
Parra Pallarés, S. 2010. Oxidized LDL and its
correlation with lipid profile and oxidative stress biomarkers in young healthy
Spanish subjects. Journal of Physiology and Biochemistry 66: 221-227.
DOI: 10.1007/s13105-010-0028-4
Casillas-Munoz,
F., Valle, Y., Muñoz-Valle, J.F., Martínez-Fernández,
D.E., Reynoso-Villalpando, G.L., Flores-Salinas,
H.E., Llamas-Covarrubias, M.A. & Padilla-Gutiérrez, J.R. 2018. APOA1 and APOB polymorphisms and apolipoprotein concentrations as biomarkers of risk in acute coronary syndrome: Relationship
with lipid-lowering therapy effectiveness. Medicina Clínica (English Edition) 151(1): 1-7. doi:10.1016/j.medcle.2018.05.001
Cavalli, S.A., Hirata, M.H., Salazar,
L.A., Diament, J., Forti,
N., Giannini, S.D., Nakandakare,
E.R., Bertolami, M.C. & Hirata, R.D. 2000. Apolipoprotein B gene polymorphisms: Prevalence and impact on serum lipid concentrations in hypercholesterolemic individuals from Brazil. Clinica Chimica Acta 302(1-2): 189-203.
https://doi.org/10.1016/S0009-8981(00)00367-3
Chen, Y.,
Lin, M., Liang, Y., Zhang, N. & Rao, S. 2016. Association between apolipoprotein b XbaI polymorphism and coronary heart disease in Han Chinese population: A
meta-analysis. Genetic Testing and Molecular Biomarkers 20(6): 304-311.
DOI: 10.1089/gtmb.2015.0126
Chen,
E.S., Mazzotti, D.R., Furuya,
T.K., Cendoroglo, M.S., Ramos, L.R., Araujo, L.Q., Burbano, R.R. & de Arruda Cardoso Smith, M. 2009. Apolipoprotein A1 gene
polymorphisms as risk factors for hypertension and obesity. Clinical and
Experimental Medicine 9: 319-325. https://doi.org/10.1007/s10238-009-0051-3
Chen, S., Xie, X., Wang, Y., Gao, Y., Xie,
X., Yang, J. & Ye, J. 2014. Association between leukocyte mitochondrial DNA
content and risk of coronary heart disease: A case-control study. Atherosclerosis 237(1): 220-226. doi:10.1016/j.atherosclerosis.2014.08.051
Chiodini, B.D., Barlera,
S., Franzosi, M.G., Beceiro,
V.L., Introna, M. & Tognoni,
G. 2003. APO B gene polymorphisms and coronary artery disease: A meta-analysis. Atherosclerosis 167(2): 355-366. DOI: 10.1016/S0021-9150(02)00425-2
Dawar, R., Gurtoo,
A. & Singh, R. 2010. Apolipoprotein A1 gene
polymorphism (G–75A and C+ 83T) in patients with myocardial infarction: A pilot
study in a north Indian population. American Journal of Clinical Pathology 134(2): 249-255.
doi:10.1309/AJCPKPTXQ3QN1IFG
Dong,
L.P. & Da Huang, W.J.C. 2018. Meta-analysis of the association between
Apo-A1 rs670, rs5069 polymorphisms and coronary artery diseases. International
Journal of Clinical and Experimental Medicine 11(7): 6445-6453.
Duman, B.S., Türkoğlu,
Ç., Akpinar, B., Güden, M., Vertii, A., Çağatay,
P., Günay, D. & Sevim Büyükdevrim, A. 2005. Genetic variations of the apolipoprotein B gene in Turkish patients with coronary
artery disease. Annals of Human Biology 32(5): 620-629.
https://doi.org/10.1080/03014460500228626
El-Sayed,
K., Almenshawy, A., El-Farahaty,
R.M., Osman, A.M. & Mahsoub, N. 2022. Association
of XbaI polymorphism of ApoB gene with lipid profile, risk factors and dietary pattern in coronary artery
disease Egyptian rural and urban patients. International Journal of Health
Sciences (Qassim) 6: 11251. DOI: 10.53730/ijhs.v6nS5.11251
Friedewald, W.T., Levy, R.I. &
Fredrickson, D.S. 1972. Estimation of the concentration of low-density
lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 18(6): 499-502.
https://doi.org/10.1093/clinchem/18.6.499
Gu, W., Zhang, M. & Wen, S. 2015.
Association between the APOB XbaI and EcoRI polymorphisms and lipids in Chinese: A meta-analysis. Lipids in Health and Disease 14: 123. DOI: 10.1186/s12944-015-0125-z
Han, Y.,
Yang, C.K., Gao, C.Y., Liu, Y.H., Cheng, J.T., Wang, X.P., Wang, Z.M. &
Cheng, T.F. 2017. Association between the ApoB/A1
ratio and the vulnerability of LMCA plaque in the patients with stable angina
pectoris. Zhonghua Yi Xue Za Zhi 97(27):
2101-2106. DOI: 10.3760/cma.j.issn.0376-2491.2017.27.005
Hanif, M.K., Fan, Y., Wang, L., Jiang,
H., Li, Z., Ma, M., Ma, L. and Ma, M. 2022. Dietary habits of patients with
coronary artery disease: A case-control study from Pakistan. International
Journal of Environmental Research and Public Health 19(14): 8635.
https://doi.org/10.3390/ijerph19148635
Hassan,
N.E., El-Masry, S.A., Zarouk,
W.A., Abd Elneam, A.I.,
Rasheed, E.A. & Mahmoud, M.M. 2015. Apolipoprotein B polymorphism distribution among a sample of obese Egyptian females with
visceral obesity and its influence on lipid profile. Journal of Genetic
Engineering and Biotechnology 13(2): 177-183. doi:
10.1016/ j.jgeb.2015.09.005
Honda,
H., Ueda, M., Kojima, S., Mashiba, S., Suzuki, H., Hosaka, N., Hirai, Y., Nakamura, M., Nagai, H., Kato, N.,
Mukai, M., Watanabe, M., Takahashi, K., Shishido, K.
& Akizawa, T. 2010. Oxidized high-density
lipoprotein is associated with protein-energy wasting in maintenance
hemodialysis patients. Clinical Journal of the American Society of
Nephrology 5(6): 1021-1028.
Hosseini-Esfahani, F., Mirmiran, P., Daneshpour, M.S., Mottaghi, A.
& Azizi, F. 2017. The effect of interactions of
single nucleotide polymorphisms of APOA1/APOC3 with food group intakes on the
risk of metabolic syndrome. Avicenna Journal of Medical Biotechnology 9(2): 94-103.
Itabe, H. & Obama, T. 2023. The
oxidized lipoproteins in vivo: Its diversity and behavior in the human
circulation. International Journal of Molecular Sciences 24(6): 5747.
https://doi.org/10.3390/ijms24065747
Lamia,
R., Asma, O., Slim, K., Jihene,
R., Imen, B., Ibtihel,
B.H., Kaouther, K., Radhia,
B., Nabila, B.R., Naoufel, N. & Ahmed, B.A. 2012.
Association of four apolipoprotein B polymorphisms
with lipid profile and stenosis in Tunisian coronary patients. Journal of
Genetics 91(1): 75-79.
Liao, B.,
Cheng, K., Dong, S., Liu, H. & Xu, Z. 2015. Effect of apolipoprotein A1 genetic polymorphisms on lipid profiles and the risk of coronary artery
disease. Diagnostic Pathology 10: 102. DOI: 10.1186/s13000-015-0328-7
Liting, P., Guoping,
L. & Zhenyue, C. 2015. Apolipoprotein B/apolipoprotein A1 ratio and non-high-density
lipoprotein cholesterol. Herz 40(Suppl 1): 1-7. https://doi.org/10.1007/s00059-014-4147-5
Liu,
Y.L., Zhang, Y.B., Li, Y., Ma, R.L., Cai, W.W.,
Lin-Jiang, L., Wang, T.S. & Yao, Z. 2014. Correlation between the Xba I polymorphism of apoB gene
and serum lipid profiles in Li ethnic group. Asian Pacific Journal of
Tropical Medicine 7(1): 63-66. doi:10.1016/S1995-7645(13)60193-5
Ma, J.,
Zhang, H.Q. & Wang, W. 2011. Relationship between apolipoprotein B, apolipoprotein E and angiotensinogen gene
polymorphisms and coronary heart disease. China Modern Doctor 49: 4-6.
Nikolajevic Starcevic,
J., Santl Letonja, M., Praznikar, Z.J., Makuc, J., Vujkovac, A.C. & Petrovic, D.
2014. Polymorphisms XbaI (rs693) and EcoRI (rs1042031) of the ApoB gene are associated with carotid plaques but not with carotid intimamedia thickness in patients with diabetes mellitus
type 2. Vasa 43: 171-180. doi:10.1024/0301-1526/a000346
Niu, C., Luo, Z., Yu, L., Yang, Y.,
Chen, Y., Luo, X., Lai, F. & Song, Y. 2017. Associations of the APOB rs693
and rs17240441 polymorphisms with plasma APOB and lipid levels: A
meta-analysis. Lipids In Health and Disease 16:
1-20. doi:10.1186/s12944-017-0558-7
Pagonas, N., Mueller, R., Weiland, L., Jaensch, M., Westhoff, T.H., Buschmann, I.R., Sasko, B.,
Ritter, O. & Kelesidis, T.H. 2020. Oxidation of
HDL in patients with coronary artery disease. European Heart Journal 41(Supplement_2): ehaa946-1521. DOI: https://doi.org/10.1093/ehjci/ehaa946.1521
Pan,
J.P., Chiang, A.N., Tai, J.J., Wang, S.P. & Chang, M.S. 1995. Restriction
fragment length polymorphisms of apolipoprotein B
gene in Chinese population with coronary heart disease. Clinical Chemistry 41: 424-429. https://doi.org/10.1093/clinchem/41.3.424
Rader,
D.J. & Hovingh, G.K. 2014. HDL and cardiovascular
disease. Lancet 384: 618-625. DOI: 10.1016/S0140-6736(14)61217-4
Rafiee, M., Sotoudeh,
G., Djalali, M., Alvandi,
E., Eshraghian, M., Javadi,
F., Doostan, F. & Koohdani,
F. 2019. The interaction between apolipoprotein B
insertion/deletion polymorphism and macronutrient intake on lipid profile and
serum leptin and ghrelin levels in type 2 diabetes mellitus patients. European
Journal of Nutrition 58: 1055-1065. DOI: 10.1007/s00394-018-1621-5
Rebhi, L., Omezzine,
A., Kchok, K., Belkahla,
R., Ben HadjMbarek, I., Rejeb,
J., Ben Rejeb, N., Nabli,
N., Bibi, A., Massoud, T. & Abdelaziz,
A. 2008. 5′ ins/del and 3′ VNTR polymorphisms in the apolipoprotein B gene in relation to lipids and coronary
artery disease. Clinical Chemical Laboratory Medicine 46: 329-334.
https://doi.org/10.1515/CCLM.2008.067
Roberts,
R., Chang, C.C. & Hadley, T. 2021. Genetic risk stratification: A paradigm shift in prevention of coronary artery disease. Journal
of American College Cardiology Basic to Translational Science 6(3):
287-304. https://doi.org/10.1016/j.jacbts.2020.09.004
Rodrigues,
A.C., Sobrino, B., Genvigir,
F.D.V., Willrich, M.A.V., Arazi,
S.S., Dorea, E.L., Bernik,
M.M.S., Bertolami, M., Faludi, A.A., Brion, M.J. & Carracedo, A.
2013. Genetic variants in genes related to lipid metabolism and
atherosclerosis, dyslipidemia and atorvastatin response. Clinica Chimica Acta 417: 8-11. doi:10.1016/j.cca.2012.11.028
Segrest, J.P., Li, L., Anantharamaiah,
G.M., Harvey, S.C., Liadaki, K.N. & Zannis, V. 2000. Structure and function of apolipoprotein A-I and high-density lipoprotein. Current
Opinion in Lipidology 11: 105-115.
Shanker, J., Perumal,
G., Rao, V.S., Khadrinarasimhiah, N.B., John, S., Hebbagodi, S., Mukherjee, M. & Kakkar,
V.V. 2008. Genetic studies on the APOA1-C3-A5 gene cluster in Asian Indians
with premature coronary artery disease. Lipids In Health and Disease 7: 33. DOI: 10.1186/1476-511X-7-33
Sharma,
R., Mahajan, M., Singh, B., Singh, G. & Singh, P. 2011. Role of the APOB gene polymorphism (c.12669G>A, p. Gln4154Lys) in coronary artery disease in
the Indian Punjabi Population. Balkan Journal of Medical Genetics 14:
35-40. doi:10.2478/v10034-011-0045-9
Sorokin,
A.V., Kotani, K., Elnabawi,
Y.A., Dey, A.K., Sajja,
A.P., Yamada, S., Ueda, M., Harrington, C.L., Baumer,
Y., Rodante, J.A. & Gelfand,
J.M. 2018. Association between oxidation-modified lipoproteins and coronary
plaque in psoriasis: An observational cohort study. Circulation Research 123(11): 1244-1254. DOI: 10.1161/circresaha.118.313608
Sotos-Prieto, M. & Peñalvo, J.L. 2013. Genetic variation of apolipoproteins, diet and other environmental interactions;
An updated review. Nutricion Hospitalaria 28(4): 999-1009.
https://www.redalyc.org/articulo.oa?id=309227544004
Srivastava,
N., Prakash, J., Srivastava, A., Agarwal, C.G., Pant, D.C. & Mittal, B.
2013. Association of apolipoprotein B XbaI gene polymorphism and lipid profile in northern Indian
obese. Indian Journal of Human Genetics 19: 26-31. doi:
10.4103/0971-6866.112880
Tsunoda, K., Harihara,
S., Tanabe, Y. & Dashnyam, B. 2012. Polymorphism
of the apolipoprotein B gene and association with
plasma lipid and lipoprotein levels in the Mongolian Buryat. Biochemical
Genetics 50: 249-268. doi:10.1007/s10528-011-9468-y
Xiao, D.,
Huang, K., Chen, Q., Huang, B., Liu, W., Peng, Y., Chen, M., Huang, D., Zou, T.
& Yang, J. 2015. Four Apolipoprotein B gene
polymorphisms and the risk for coronary artery disease: A meta-analysis of 47
studies. Genes and Genomics 37: 621-632. doi:10.1007/s13258-015-0292-3
Zhang,
P., Gao, J., Pu, C. & Zhang, Y. 2017. Apolipoprotein status in type 2 diabetes mellitus and its complications. Molecular Medicine
Reports 16(6): 9279-9286. https://doi.org/10.3892/mmr.2017.7831
*Pengarang untuk surat-menyurat;
email: hirasohail@cmhlahore.edu.pk
|